| Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients E Morsia, K McCullough, M Joshi, J Cook, HB Alkhateeb, A Al‐Kali, ... American journal of hematology 95 (12), 1511-1521, 2020 | 96 | 2020 |
| Evaluating unconscious bias: speaker introductions at an international oncology conference N Duma, U Durani, CB Woods, LA Kankeu Fonkoua, JM Cook, C Wee, ... Journal of Clinical Oncology 37 (36), 3538-3545, 2019 | 72 | 2019 |
| Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma J Cook, KW Peng, TE Witzig, SM Broski, JC Villasboas, J Paludo, ... Blood Advances 6 (11), 3268-3279, 2022 | 30 | 2022 |
| Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation M Joshi, J Cook, K McCullough, A Nanaa, N Gangat, JM Foran, ... Blood cancer journal 11 (3), 49, 2021 | 30 | 2021 |
| Photon-counting detector CT with deep learning noise reduction to detect multiple myeloma FI Baffour, NR Huber, A Ferrero, K Rajendran, KN Glazebrook, NB Larson, ... Radiology 306 (1), 229-236, 2023 | 28 | 2023 |
| Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma J Cook, I Johnson, A Higgins, S Sidana, R Warsame, W Gonsalves, ... American journal of hematology 96 (3), 330-337, 2021 | 14 | 2021 |
| Updates in the diagnosis and management of AL amyloidosis J Cook, E Muchtar, R Warsame Current Hematologic Malignancy Reports 15, 155-167, 2020 | 13 | 2020 |
| Advances in supportive care for acute lymphoblastic leukemia J Cook, M Litzow Current Hematologic Malignancy Reports 15, 276-293, 2020 | 12 | 2020 |
| Deep learning‐based virtual noncalcium imaging in multiple myeloma using dual‐energy CT H Gong, FI Baffour, KN Glazebrook, NG Rhodes, CA Tiegs‐Heiden, ... Medical physics 49 (10), 6346-6358, 2022 | 10 | 2022 |
| Immune recovery post unrelated allogeneic umbilical cord blood (UCB) transplantation in adult recipients. MJ Laughlin, K McKinnon, J Demarest, R Buckley, K Weinhold, ... Blood 90 (10), 1868-1868, 1997 | 10 | 1997 |
| Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies A Visram, J Cook, R Warsame Hematology 2021 (1), 673-681, 2021 | 9 | 2021 |
| Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis BA Pitel, N Sharma, C Zepeda-Mendoza, JB Smadbeck, KE Pearce, ... Blood cancer journal 11 (2), 18, 2021 | 9 | 2021 |
| First reported case of hemopericardium related to dabigatran use reversed by new antidote idarucizumab S Song, J Cook, C Goulbourne, M Meade, L Salciccioli, J Lazar Case Reports in Cardiology 2017, 2017 | 9 | 2017 |
| Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma. J Cook, KW Peng, SM Geyer, BF Ginos, AC Dueck, N Packiriswamy, ... Journal of Clinical Oncology 39 (15_suppl), 2500-2500, 2021 | 7 | 2021 |
| Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy C Charalampous, U Goel, P Kapoor, M Binder, FK Buadi, J Cook, D Dingli, ... Blood advances 7 (16), 4371-4380, 2023 | 6 | 2023 |
| Prognostic significance of acquired 1q22 gain in multiple myeloma HY Audil, JM Cook, PT Greipp, P Kapoor, LB Baughn, A Dispenzieri, ... American journal of hematology 97 (1), 52-59, 2022 | 6 | 2022 |
| Assessment of discrimination, bias, and inclusion in a United States hematology and oncology fellowship program RM Warsame, GB Asiedu, A Kumbamu, J Cook, SN Hayes, CA Thompson, ... JAMA Network Open 4 (11), e2133199-e2133199, 2021 | 5 | 2021 |
| Oncolytic virotherapy–forging its place in the immunomodulatory paradigm for Multiple Myeloma J Cook, AA Acosta-Medina, KW Peng, M Lacy, S Russell Cancer Treatment and Research Communications 29, 100473, 2021 | 4 | 2021 |
| Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas U Yadav, SK Kumar, LB Baughn, A Dispenzieri, P Greipp, R Ketterling, ... Blood 142 (22), 1871-1878, 2023 | 3 | 2023 |
| Long-term outcomes of allogeneic stem cell transplant in multiple myeloma WM Schmidt, ND Perera, FK Buadi, SR Hayman, SK Kumar, A Dispenzieri, ... Blood cancer journal 13 (1), 126, 2023 | 3 | 2023 |
Martha Q. Lacy, MDProfessor of Medicine, Mayo ClinicVerified email at mayo.edu
